IN2014DN10077A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10077A
IN2014DN10077A IN10077DEN2014A IN2014DN10077A IN 2014DN10077 A IN2014DN10077 A IN 2014DN10077A IN 10077DEN2014 A IN10077DEN2014 A IN 10077DEN2014A IN 2014DN10077 A IN2014DN10077 A IN 2014DN10077A
Authority
IN
India
Prior art keywords
carbon content
organic carbon
less
during
total organic
Prior art date
Application number
Inventor
Kazuhiro Obae
Masayuki Kakizawa
Mitsuo Yamashita
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Publication of IN2014DN10077A publication Critical patent/IN2014DN10077A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/122—Pulverisation by spraying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates
    • C08K5/053—Polyhydroxylic alcohols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/20—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/04—Oxycellulose; Hydrocellulose

Abstract

This cellulose powder has: an average degree of polymerization of 100 to 300; a weight average particle size of over 30 µm, but less than 250 µm; an apparent specific volume of 2.0 cm/g to less than 4.0 cm/g; and an organic carbon content from residual impurities , which is defined by the total organic carbon content (%) during 1% NaOH extraction to the total organic carbon content (%) during pure water extraction , of 0.002 to 0.060%.
IN10077DEN2014 2012-05-31 2013-05-30 IN2014DN10077A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012124016 2012-05-31
PCT/JP2013/065111 WO2013180246A1 (en) 2012-05-31 2013-05-30 Cellulose powder

Publications (1)

Publication Number Publication Date
IN2014DN10077A true IN2014DN10077A (en) 2015-08-21

Family

ID=49673433

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10077DEN2014 IN2014DN10077A (en) 2012-05-31 2013-05-30

Country Status (3)

Country Link
JP (3) JP6210981B2 (en)
IN (1) IN2014DN10077A (en)
WO (1) WO2013180246A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6210981B2 (en) * 2012-05-31 2017-10-11 旭化成株式会社 Cellulose powder
JP5950012B1 (en) * 2015-09-17 2016-07-13 王子ホールディングス株式会社 Method for producing fine fibrous cellulose-containing material
JP6638290B2 (en) * 2015-09-30 2020-01-29 日本製紙株式会社 Powdered cellulose
BR112021011263A2 (en) * 2018-12-27 2021-08-31 Asahi Kasei Kabushiki Kaisha CELLULOSE POWDER, USE OF IT, AND TABLETS
WO2020202598A1 (en) * 2019-04-02 2020-10-08 旭化成株式会社 Cellulose powder, tablet, and tablet production method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420126A (en) * 1977-07-12 1979-02-15 Asahi Chem Ind Co Ltd Pharmaceutical composition
JP3534130B2 (en) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 Pharmaceutical composition
EP1300420B1 (en) * 2000-07-05 2015-11-18 Asahi Kasei Kabushiki Kaisha Cellulose powder
CN100465214C (en) * 2003-05-30 2009-03-04 旭化成化学株式会社 Cellulose powder
JP2005232260A (en) * 2004-02-18 2005-09-02 Asahi Kasei Chemicals Corp Porous composite particle of cellulose inorganic compound
US8153157B2 (en) * 2005-04-22 2012-04-10 Asahi Kasei Chemicals Corporation Porous cellulose aggregate and molding composition thereof
WO2009157564A1 (en) * 2008-06-26 2009-12-30 旭化成ケミカルズ株式会社 Cellulose composition
JP5430091B2 (en) * 2008-07-09 2014-02-26 旭化成せんい株式会社 Superabsorbent resin and method for producing the same
WO2012002253A1 (en) * 2010-06-29 2012-01-05 旭化成ケミカルズ株式会社 Composite particles which contain both cellulose and inorganic compound
US9358417B2 (en) * 2011-06-06 2016-06-07 Trudell Medical International Oscillating positive expiratory pressure device
JP6210981B2 (en) * 2012-05-31 2017-10-11 旭化成株式会社 Cellulose powder
IN2014DN10072A (en) * 2012-05-31 2015-08-14 Asahi Kasei Chemicals Corp
JP6104905B2 (en) * 2012-05-31 2017-03-29 旭化成株式会社 Cellulose powder
JP6413940B2 (en) * 2015-06-11 2018-10-31 株式会社デンソー Driving assistance device

Also Published As

Publication number Publication date
JPWO2013180246A1 (en) 2016-01-21
JP6383835B2 (en) 2018-08-29
JP2017165972A (en) 2017-09-21
JP2018172699A (en) 2018-11-08
JP6210981B2 (en) 2017-10-11
WO2013180246A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
IN2014DN10072A (en)
IN2014DN10076A (en)
IN2014DN10077A (en)
MX2014015389A (en) Methods for increasing the extractable rubber content of non-hevea plant matter.
IN2014CN02317A (en)
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
MX364734B (en) Processes for recovering rubber from aged briquettes and aged briquettes containing plant matter from non-hevea plants.
EP3838930A3 (en) Polymerisation process
MX2013010889A (en) Process for preparing self-binding pigment particles.
MX2020008008A (en) Process for bacterially devulcanizing sulphur-vulcanized rubber particles.
IN2015MN00013A (en)
MY158032A (en) Treatment method for palm trunk
WO2015145054A3 (en) Implantable biocompatible reactor
MY163074A (en) Formulations comprising methylthioninium chloride
MX2012010850A (en) Continuous process for preparing polyfluoroacrylate particles.
MY175060A (en) Method for processing rubber granules or rubber powders
MY162164A (en) Process for production of polymer nanocomposites
GB201008401D0 (en) Novel process
MX2012014199A (en) Iron (iii) caseinsuccinylate and method for the preparation thereof.
PT2928927T (en) Process to produce polyvinyl-ester compositions with low residual monomer content
MY168546A (en) Composite metal hydroxide particles and resin composition containing the same
IN2012DN06607A (en)
CN105616249A (en) Nutrient solution for helping wound recovery
MX2013012004A (en) Process for obtaining a flour reduced in astringency, with a high content of fiber, vitamin a and vitamin c from the cashew pseudocarp (anacardium occidentale l.), uses and applications thereof.
MY171853A (en) Sphingomyelin-containing supplement